Evolus reported an atrocious quarter

by Biotech Newsroom


Word Count: 2,216 words, Reading Time: 10 minutes. Not financial advice, do your own due diligence, for entertainment purposes only.

Subscribers: Substack is telling me this post is too long for email so please load in browser if the bottom is cut off.

Evolus is technically a biotech company but they describe themselves as a “performance beauty” company and the market would likely describe them as a pure play aesthetics company. Either way, they quality for coverage by the definition of this newsletter because their products, JEUVEAU, a…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC